Non-Invasive Genomic Biomarker Monitoring to Improve Long-Term Transplant Outcomes
Transplant Genomics aims to improve transplant outcomes through molecular diagnostic tests that detect early signs of graft injury, differentiate among actionable causes, and enable optimization of therapy.
≥75% of patients who have surveillance biopsies show normal histology, and the vast majority could have been spared an invasive procedure
≥20% of patients show subclinical acute rejection